supporters of controversial efforts to patent human genes won a victory at the weekend with the resignation of mr james watson as head of the us government's human gene research project mr watson a nobel prize winner for his part in discovering the dna double helix is an outspoken opponent of recent attempts to patent pieces of human genes the issue has divided scientific communities in the us japan and europe which are mapping all 100,000 genes in the human body at stake is the potential for billions of dollars of revenue from buyers of genetic information such as drug companies mr watson was director of the human genome project the washington-based federal research organisation the project is part of the national institute of health nih the us federal agency which is spending more than dollars 150 m pounds 87.2 m a year on the 20-year programme the ec and japan are each putting in about one fifth as much again into the same project at local research establishments mr watson's resignation comes at the same time as an inquiry by the nih ethics officer into a potential conflict of interest because of his shareholdings in biotechnology companies however many believe he left because of policy differences with ms bernadine healy who became director of the nih last year mr watson handed in his resignation on friday saying it would allow ms healy to appoint her own director of the genome project debate over the patenting of human genes reached a head last summer after a us laboratory filed under the auspices of the nih 347 patents for pieces of human dna virtually all scientists have opposed this said sir walter bodmer president of the human genome organisation which co-ordinates human genome research globally